Souliotis VL - Search Results

1

Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis.

Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Sfikakis PP, et al. Among authors: souliotis vl. Clin Immunol. 2007 Apr;123(1):66-73. doi: 10.1016/j.clim.2006.12.006. Epub 2007 Jan 31. Clin Immunol. 2007. PMID: 17275413

2

Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells.

Sfikakis PP, Souliotis VL, Panayiotidis PP. Sfikakis PP, et al. Among authors: souliotis vl. Arthritis Rheum. 1993 Feb;36(2):208-12. doi: 10.1002/art.1780360211. Arthritis Rheum. 1993. PMID: 8431210

3

Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes.

Sfikakis PP, Souliotis VL, Katsilambros N, Markakis K, Vaiopoulos G, Tsokos GC, Panayiotidis P. Sfikakis PP, et al. Among authors: souliotis vl. Clin Immunol Immunopathol. 1996 Apr;79(1):43-9. doi: 10.1006/clin.1996.0049. Clin Immunol Immunopathol. 1996. PMID: 8612350

4

Regulation of bcl-2 and fas expression in primary activation of human peripheral lymphocytes is not sensitive to dexamethasone or cyclosporin-A.

Sfikakis PP, Souliotis VL, Akbar AN, Katsilambros N, Hoffbrand VA, Panayiotidis P. Sfikakis PP, et al. Among authors: souliotis vl. Hum Immunol. 1996 Oct;50(2):121-6. doi: 10.1016/0198-8859(96)00136-x. Hum Immunol. 1996. PMID: 8891735

5

Effects of 2-chlorodeoxyadenosine and gold sodium thiomalate on human bcl-2 gene expression.

Sfikakis PP, Dimopoulos MA, Souliotis VL, Charalambopoulos D, Mavrikakis M, Panayiotidis P. Sfikakis PP, et al. Among authors: souliotis vl. Immunopharmacol Immunotoxicol. 1998 Feb;20(1):63-77. doi: 10.3109/08923979809034809. Immunopharmacol Immunotoxicol. 1998. PMID: 9543700

6

Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus.

Katsiari CG, Liossis SN, Souliotis VL, Dimopoulos AM, Manoussakis MN, Sfikakis PP. Katsiari CG, et al. Among authors: souliotis vl. Clin Immunol. 2002 Apr;103(1):54-62. doi: 10.1006/clim.2001.5172. Clin Immunol. 2002. PMID: 11987985

7

Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.

Souliotis VL, Dimopoulos MA, Sfikakis PP. Souliotis VL, et al. Clin Cancer Res. 2003 Oct 1;9(12):4465-74. Clin Cancer Res. 2003. PMID: 14555520

8

Intra- and intercellular variations in the repair efficiency of O6-methylguanine, and their contribution to kinetic complexity.

Souliotis VL, Sfikakis PP, Anderson LM, Kyrtopoulos SA. Souliotis VL, et al. Mutat Res. 2004 Dec 21;568(2):155-70. doi: 10.1016/j.mrfmmm.2004.07.009. Mutat Res. 2004. PMID: 15542103

9

Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome.

Dimopoulos MA, Souliotis VL, Anagnostopoulos A, Papadimitriou C, Sfikakis PP. Dimopoulos MA, et al. Among authors: souliotis vl. J Clin Oncol. 2005 Jul 1;23(19):4381-9. doi: 10.1200/JCO.2005.07.385. Epub 2005 May 9. J Clin Oncol. 2005. PMID: 15883412

10

Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure.

Souliotis VL, Dimopoulos MA, Episkopou HG, Kyrtopoulos SA, Sfikakis PP. Souliotis VL, et al. DNA Repair (Amst). 2006 Aug 13;5(8):972-85. doi: 10.1016/j.dnarep.2006.05.006. Epub 2006 Jun 15. DNA Repair (Amst). 2006. PMID: 16781199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page